MiR-137 effects on gastric carcinogenesis are mediated by targeting Cox-2-activated PI3K/AKT signaling pathway

FEBS Letters

Volumn 588, Issue 17, 2014, Pages 3274-3281

  Cheng, Yan ^a   Li, Yang ^a   Liu, Dong ^a   Zhang, Rong ^a   Zhang, Jun ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Cyclooxygenase 2; miR 137; PI3K AKT signaling pathway; Stomach neoplasm; Xenograft tumor

Indexed keywords

CYCLOOXYGENASE 2; MICRORNA; MICRORNA 137; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; COX 2 GENE; ENZYME ACTIVATION; ENZYME REPRESSION; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; STOMACH CARCINOGENESIS; TUMOR INVASION;

CYCLOOXYGENASE-2; MIR-137; PI3K/AKT SIGNALING PATHWAY; STOMACH NEOPLASM; XENOGRAFT TUMOR;

CARCINOGENESIS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLOOXYGENASE 2; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS;

EID: 84906277423     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2014.07.012     Document Type: Article

References (31)

1. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int. J. Cancer 127 2010 2893 2917
2. O. Kanat, and B.H. O'Neil Metastatic gastric cancer treatment: a little slow but worthy progress Med. Oncol. 30 2013 464
3. R.S. Gill, D.P. Al-Adra, J. Nagendran, S. Campbell, X. Shi, E. Haase, and D. Schiller Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: a systematic review of survival, mortality, and morbidity J. Surg. Oncol. 104 2011 692 698
4. H.I. Grabsch, and P. Tan Gastric cancer pathology and underlying molecular mechanisms Dig. Surg. 30 2013 150 158
5. A. Hui, C. How, E. Ito, and F.F. Liu Micro-RNAs as diagnostic or prognostic markers in human epithelial malignancies BMC Cancer 11 2011 500
6. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
7. A.M. Gurtan, and P.A. Sharp The role of miRNAs in regulating gene expression networks J. Mol. Biol. 425 2013 3582 3600
8. Y. Zhao, Y. Li, G. Lou, L. Zhao, Z. Xu, Y. Zhang, and F. He MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cells PLoS One 7 2012 e39102
9. M. Liu et al. MiR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells Int. J. Cancer 128 2011 1269 1279
10. X. Zhu, Y. Li, H. Shen, H. Li, L. Long, L. Hui, and W. Xu MiR-137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6 FEBS Lett. 587 2013 73 81
11. Y. Du, Z. Liu, L. Gu, J. Zhou, B.D. Zhu, J. Ji, and D. Deng Characterization of human gastric carcinoma-related methylation of 9 miR CpG islands and repression of their expressions in vitro and in vivo BMC Cancer 12 2012 249
12. L. Feng, W. Sun, Y. Xia, W.W. Tang, P. Chanmugam, E. Soyoola, C.B. Wilson, and D. Hwang Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression Arch. Biochem. Biophys. 307 1993 361 368
13. W. Xie, Q. Zheng, G. Lei, and Z. Han Anti-implantation action of nylestriol and its effect on endometrium in rabbits Hua Xi Yi Ke Da Xue Xue Bao 25 1994 45 49
14. D.L. Simmons, R.M. Botting, and T. Hla Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition Pharmacol. Rev. 56 2004 387 437
15. A. Thiel, J. Mrena, and A. Ristimaki Cyclooxygenase-2 and gastric cancer Cancer Metastasis Rev. 30 2011 387 395
16. G. Erkan, I.I. Gonul, U. Kandilci, and A. Dursun Assessment of COX-2 expression presence and severity by immunohistochemical method in patients with chronic active gastritis and intestinal metaplasia Turk. J. Gastroenterol. 23 2012 478 484
17. J. Mrena et al. Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR Clin. Cancer Res. 11 2005 7362 7368
18. Q. Chen, X. Chen, M. Zhang, Q. Fan, S. Luo, and X. Cao MiR-137 is frequently down-regulated in gastric cancer and is a negative regulator of Cdc42 Dig. Dis. Sci. 56 2011 2009 2016
19. C.J. Li, J.K. Chang, G.J. Wang, and M.L. Ho Constitutively expressed COX-2 in osteoblasts positively regulates Akt signal transduction via suppression of PTEN activity Bone 48 2011 286 297
20. Y.W. Kong, D. Ferland-McCollough, T.J. Jackson, and M. Bushell MicroRNAs in cancer management Lancet Oncol. 13 2012 e249 e258
21. H. Lei et al. MicroRNA-219-2-3p functions as a tumor suppressor in gastric cancer and is regulated by DNA methylation PLoS One 8 2013 e60369
22. Y. Deng et al. MiR-215 modulates gastric cancer cell proliferation by targeting RB1 Cancer Lett. 2013
23. M. Blanco-Calvo, L. Calvo, A. Figueroa, M. Haz-Conde, L. Anton-Aparicio, and M. Valladares-Ayerbes Circulating microRNAs: molecular microsensors in gastrointestinal cancer Sensors (Basel) 12 2012 9349 9362
24. L. Chen et al. MiR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2 Eur. J. Cancer 48 2012 3104 3111
25. M. Hotfilder, P. Sondermann, A. Senss, F. van Valen, H. Jurgens, and J. Vormoor PI3K/AKT is involved in mediating survival signals that rescue Ewing tumour cells from fibroblast growth factor 2-induced cell death Br. J. Cancer 92 2005 705 710
26. E. Martin-Sanchez et al. Simultaneous inhibition of pan- phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas Haematologica 98 2013 57 64
27. L. Zhao, Y.Y. Sha, Q. Zhao, J. Yao, B.B. Zhu, Z.J. Lu, Q.D. You, and Q.L. Guo Enhanced 5-fluorouracil cytotoxicity in high COX-2 expressing hepatocellular carcinoma cells by wogonin via the PI3K/Akt pathway Biochem. Cell Biol. 91 2013 221 229
28. B.T. Vo, D. Morton Jr., S. Komaragiri, A.C. Millena, C. Leath, and S.A. Khan TGF-beta effects on prostate cancer cell migration and invasion are mediated by PGE2 through activation of PI3K/AKT/mTOR pathway Endocrinology 154 2013 1768 1779
29. V. Gonzalez-Villasana, Y. Gutierrez-Puente, and A.M. Tari Cyclooxygenase-2 utilizes Jun N-terminal kinases to induce invasion, but not tamoxifen resistance, in MCF-7 breast cancer cells Oncol. Rep. 30 2013 1506 1510
30. Y.B. Ding et al. PGE2 up-regulates vascular endothelial growth factor expression in MKN28 gastric cancer cells via epidermal growth factor receptor signaling system Exp. Oncol. 27 2005 108 113
31. Y.G. Fu et al. Inhibition of gastric cancer-associated angiogenesis by antisense COX-2 transfectants Cancer Lett. 224 2005 243 252